Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts
Title
Grant Type
Focus Area
Country
Application Due Date
BCMA-Directed Bispecific Antibody Treatment in Multiple Myeloma
Release Date:
Review Process: Pfizer Internal
Translation: Japanese (link)
Education Oncology Japan
Research on MBL producing Enterobacterales and/or Stenotrophomonas maltophilia
Release Date:
Review Process: Pfizer Internal
Research Hospital Austria, Brazil, China, France, Germany, Greece, India, Italy, Mexico, Saudi Arabia, Spain, Taiwan, Turkey, United Kingdom
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options (Global excluding United States)
Release Date:
Review Process: Pfizer Internal
Education Rare Disease All
Optimal management of patients with prostate cancer receiving androgen deprivation therapy (ADT)
Release Date:
Partner: Sumitomo Pharma
Review Process: Pfizer Internal
Education Oncology USA
Title
Grant Type
Focus Area
Country
Application Due Date
Understanding Healthcare disparities in IBD Patients in Underserved Communities
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology Canada, USA
Latin America Needs Assessment of Mental Health
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Argentina, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela
Raising Awareness and Promoting Timely Diagnosis of TTR Amyloidosis
Release Date:
Partner: Mayo Clinic
Review Process: Expert Review Panel
Translation: French (link)
Translation: Spanish (link)
Translation: Mandarin (link)
Translation: Arabic (link)
Quality Improvement Rare Disease All
Identifying and Diagnosing Juvenile Idiopathic Arthritis (JIA)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Antibiotic Stewardship in Pediatrics
Release Date:
Review Process: Pfizer Internal
Quality Improvement Hospital All
China Educational Needs Assessment in Atopic Dermatitis
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology China
China Medical Education in Atopic Dermatitis Awareness and Treatment
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology China
Improve the Treatment Environment for Cancer Pain Patients
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
Appropriate Immunization among Patients with Immune-Mediated Inflammatory Diseases (IMIDs)
Release Date:
Review Process: Pfizer Internal
Quality Improvement Inflammation & Immunology All
Promoting Pain Treatment in Osteoarthritis Care
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan
Improving the Knowledge Gap on Vaccine Safety Assessment
Release Date:
Review Process: Pfizer Internal
Education Vaccines Japan
Promotion of the Appropriate Diagnosis and Treatment of Pediatric Neurogenic Bladder
Release Date:
Review Process: Pfizer Internal
Education Internal Medicine Japan